Role of Microrna-27A in the Anti-Apoptotic Effects of Liraglutide in Cardiomyocytes
Min Yao,Xiaoming Wu,Huanxin Ren,Shengqian Zhu,Jia Liu,Hong Zhang,Wei Zhao
DOI: https://doi.org/10.3760/cma.j.issn.1674-5809.2017.04.008
2017-01-01
Abstract:Objective To investigate the role of MicroRNA-27a (miR-27a) in the anti-apoptotic effects of liraglutide (LR) in cardiomyocytes. Methods The H9c2 rat cardiomyocytes were cultured in different environment and divided into low glucose group, high glucose group, miR-27a over-expression group, miR-27a inhibited group, miR-27a negative over-expression group, miR-27a negative inhibited group, liposome 2000 group, hypertonic solution group, LR intervention group, LR intervention and miR-27a over-expression group, LR intervention and miR-27a negative over-expression group. The expression of miR-27a in cardiomyocytes, which were cultured in low glucose solution, high glucose solution and interferenced by LR, was detected by fluorescence-based real-time quantitative polymerase chain reaction (PCR). The apoptosis of cardiomyocytes was detected by terminal-deoxynucleoitidyl transferase mediated nick end labeling (TUNEL) and then the cell apoptosis index (AI) was computed and compared among the groups. The expression of apoptosis-related protein B-cell lymphoma/leukemia-2 (Bcl-2), Bcl-2 associated X protein (Bax), cysteine-containing aspartate-specific proteases-3 (caspase-3), cellular inhibitors of apoptosis-1 (cIAP-1), anti-apoptotic protease activating factor-1 (Apaf-1) was detected by Western blotting method. Data were analyzed with one-way analysis of variance test or t test. Results The expression of miR-27a in high glucose group was higher than that in low glucose group(35.8±4.9 vs 1.0±0.0, t=12.199, P<0.05). Compared with the high glucose group, the AI of cardiomyocytes increased significantly in miR-27a over-expression group (78.5 ± 6.6 vs 22.9 ± 1.7, least-significant difference (LSD), P<0.05), and the protein expression of Bcl-2 and cIAP-1 decreased (LSD, both P<0.05), the protein expression of Bax, caspase-3 and Apaf-1 increased(LSD, all P<0.05). Compared with the high glucose group, the AI of cardiomyocytes decreased significantly in miR-27a inhibition group (2.6 ± 0.4 vs 22.9 ± 1.7, LSD, P<0.05), and the protein expression level of Bcl-2 and cIAP-1 increased (LSD, both P<0.05), the protein expression level of Bax, caspase-3 and Apaf-1 significantly decreased(LSD, all P<0.05). Compared with the high glucose group, the expression level of miR-27a decreased significantly in LR intervention group (7.9 ± 0.2 vs 35.8 ± 4.9, t=-9.785, P<0.05), and the AI of cardiomyocytes decreased remarkably (4.9±0.1 vs 22.9±1.7, LSD, P<0.05). The AI of cardiomyocytes increased in LR intervention and miR-27a over-expression group when compared with that in LR intervention group (61.3 ± 5.1 vs 4.9 ± 0.1, LSD, P<0.05). Conclusion LR may ameliorate the apoptosis of cardiomyocytes in the condition of high glucose by inhibiting the expression of miR-27a in H9c2 rat cardiomyocytes.